Evidence map›Paper›PMID 40035673›Full record

ArticleRadiology2025

The Diagnostic Accuracy of

Jelijn J Knip, Ramsha Iqbal, Emma C Bonjer, Lemonitsa H Mammatas, Annette A van Zweeden, Paola Perin, Jaap J M Teunissen, Gwen M P Diepenhorst, Laura J Schijf, Sandra D Bakker and 10 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Radiology · 2025
    Article
4 · The record

Corrections and comments

  • Commented on by
    2025
5 · Who and what money

Authors and funding

20 authors.

Jelijn J Knip *From the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0009-0009-6055-0446
Ramsha Iqbal *From the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Emma C BonjerFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0009-0009-4228-106X
Lemonitsa H MammatasFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0001-9720-7769
Annette A van ZweedenFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Paola PerinFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Jaap J M TeunissenFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0002-1744-7701
Gwen M P DiepenhorstFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Laura J SchijfFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Sandra D BakkerFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0003-3936-4648
Noortje SchoenmakersFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Susanne van der VeldeFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Ellis BarbéFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Katya DuvivierFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0002-8713-0443
Inge R KoningsFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Gerben J C ZwezerijnenFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0002-9571-9362
Albert D WindhorstFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0002-1250-7656
Ronald BoellaardFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
Daniela E Oprea-LagerFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).
C Willemien Menke-van der Houven van OordtFrom the Departments of Medical Oncology (J.J.K., R.I., E.C.B., I.R.K., C.W.M.v.d.H.v.O.), Surgery (G.M.P.D., S.v.d.V.), Radiology and Nuclear Medicine (L.J.S., K.D., G.J.C.Z., A.D.W., R.B., D.E.O.L.), and Pathology (E.B.), Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands (J.J.K., R.I., I.R.K., G.J.C.Z., R.B., D.E.O.L., C.W.M.v.d.H.v.O.); Departments of Medical Oncology (L.H.M.) and Nuclear Medicine (J.J.M.T.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Medical Oncology, Ziekenhuis Amstelland, Amstelveen, the Netherlands (A.A.v.Z., P.P.); Department of Surgery, Flevoziekenhuis, Almere, the Netherlands (G.M.P.D.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands (L.J.S.); Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands (S.D.B.); and Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, the Netherlands (N.S.).ORCID 0000-0002-5404-5883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background According to current guidelines, staging of patients with locally advanced breast cancer and local-regional recurrent breast cancer is preferably performed with PET using 2-fluorine 18-fluoro-2-deoxy-d-glucose (

Indexed as

Breast NeoplasmsEstradiolFluorodeoxyglucose F18Positron-Emission TomographyAdultAgedBreastFemaleHumansMiddle AgedNeoplasm GradingNeoplasm StagingPilot ProjectsProspective StudiesRadiopharmaceuticalsReceptors, Estrogen16-fluoroestradiolEstradiolFluorodeoxyglucose F18RadiopharmaceuticalsReceptors, Estrogen

Identifiers

PMID40035673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.